1st European CAR T Cell Meeting
The European CAR T Meeting provides the ideal context to meet these learning objectives, with speakers who will share first-hand experience, including presenters from the United States who pioneered the field and representatives of the EU-funded projects CARAMBA (https://www.caramba-cart.eu) and EURE-CART (http://www.eure-cart.eu). The programme includes a comprehensive outlook on the current research efforts to increase CAR T cell therapies efficacy and targets, with input from basic researchers as well as representatives from the industry.
This meeting will cover the following topics:
• Pre-clinical pipeline: novel CAR technologies and targets,
• CAR T therapies currently tested and used in the clinics,
• Safety/clinical management of CAR T patients,
• Optimal patient selection for treatment with CAR T,
• Industry perspective and hospital perspective in manufacturing and administering CAR T,
• Practical solutions in the handling of apheresis and clinical application of CAR T cells,
• Nurses training,
• Regulatory aspects, health economics, and reimbursement for CAR T, and
• Centre Qualification, documentation and implementation of a quality management system.
Chair: H Einsele, C Chabannon
Co-chair: M Hudecek (coordinator CARAMBA project)
With key-note lectures: Carl June, Michel Sadelain and Stanley Riddell
For the complete programme, please visit:
EHA website https://ehaweb.org/meetings/swg-immunotherapy/scientific-program/
or the EBMT website https://www.ebmt.org/events/1st-european-car-t-cell-meeting
Keywords
CAR-T, hematology, myeloma, leukemia